Ruilin Ding

Luzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Landscape analysis of clinical trials evaluating antibody-drug conjugates in the neoadjuvant and adjuvant settings for solid tumors.

Landscape analysis of clinical trials evaluating antibody-drug conjugates in the neoadjuvant and adjuvant settings for solid tumors.

Journal: International journal of surgery (London, England)

Published: September 29, 2025

Breaking therapeutic barriers in solid tumors: Clinical progress of antibody‑drug conjugate/immune checkpoint inhibitor combinations (Review).

Breaking therapeutic barriers in solid tumors: Clinical progress of antibody‑drug conjugate/immune checkpoint inhibitor combinations (Review).

Journal: Oncology reports

Published: April 25, 2025

Integrated bioinformatics and experiment validation reveal cuproptosis-related biomarkers and therapeutic targets in sepsis-induced myocardial dysfunction.

Integrated bioinformatics and experiment validation reveal cuproptosis-related biomarkers and therapeutic targets in sepsis-induced myocardial dysfunction.

Journal: BMC infectious diseases

Published: November 21, 2024

Validation of Senescence of the Role of ATM/P53 Pathway in Myocardial Senescence in Mice with Sepsis.

Validation of Senescence of the Role of ATM/P53 Pathway in Myocardial Senescence in Mice with Sepsis.

Journal: Infection and drug resistance

Published: November 19, 2024

A dose-escalation study of HP501, a highly selective URAT1 inhibitor, in male Chinese patients with hyperuricemia.

A dose-escalation study of HP501, a highly selective URAT1 inhibitor, in male Chinese patients with hyperuricemia.

Journal: Scientific reports

Published: October 17, 2023

Prognostic models for predicting overall and cancer-specific survival of patients with initially diagnosed metastatic cervical squamous cell carcinoma: A study based on SEER database.

Prognostic models for predicting overall and cancer-specific survival of patients with initially diagnosed metastatic cervical squamous cell carcinoma: A study based on SEER database.

Journal: Medicine

Published: July 14, 2023

A Phase I Study to Evaluate the Pharmacokinetic Drug‒Drug Interaction of HP501, Febuxostat, and Colchicine in Male Chinese Patients with Hyperuricemia.

A Phase I Study to Evaluate the Pharmacokinetic Drug‒Drug Interaction of HP501, Febuxostat, and Colchicine in Male Chinese Patients with Hyperuricemia.

Journal: Clinical drug investigation

Published: May 07, 2023

PROTACs in gastrointestinal cancers.

PROTACs in gastrointestinal cancers.

Journal: Molecular therapy oncolytics

Published: November 24, 2022

New insights of necroptosis and immune infiltration in sepsis-induced myocardial dysfunction from bioinformatics analysis through RNA-seq in mice.

New insights of necroptosis and immune infiltration in sepsis-induced myocardial dysfunction from bioinformatics analysis through RNA-seq in mice.

Journal: Frontiers in cellular and infection microbiology

Published: October 12, 2022

Therapeutic targeting of VEGF and/or TGF-β to enhance anti-PD-(L)1 therapy: The evidence from clinical trials.

Therapeutic targeting of VEGF and/or TGF-β to enhance anti-PD-(L)1 therapy: The evidence from clinical trials.

Journal: Frontiers in oncology

Published: March 27, 2022

Long non‑coding RNA HCG11 suppresses the malignant phenotype of non‑small cell lung cancer cells by targeting a miR‑875/SATB2 axis.

Long non‑coding RNA HCG11 suppresses the malignant phenotype of non‑small cell lung cancer cells by targeting a miR‑875/SATB2 axis.

Journal: Molecular medicine reports

Published: August 07, 2020

Novel therapies for malignant pleural effusion: Anti‑angiogenic therapy and immunotherapy (Review).

Novel therapies for malignant pleural effusion: Anti‑angiogenic therapy and immunotherapy (Review).

Journal: International journal of oncology

Published: June 29, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026